Mild neonatal hypoxic-ischemic encephalopathy: current evidence and ongoing controversies

Area of Science:

• Neonatal Neurology
• Perinatal Medicine
• Neuroprotection

Background:

• Neonatal hypoxic-ischemic encephalopathy (HIE) is a significant global cause of infant death and disability.
• Therapeutic hypothermia (TH) is standard for moderate-to-severe HIE, but its use in mild HIE is debated.
• Mild HIE cases were historically excluded from major TH trials.

Purpose of the Study:

• To review existing evidence on neurodevelopmental outcomes in infants with mild HIE.
• To critically evaluate the data supporting TH use in mild HIE cases.
• To identify knowledge gaps and future research needs.

Main Methods:

• Systematic review of current literature on mild HIE and TH.
• Analysis of observational studies on neurodevelopmental outcomes.
• Critical appraisal of diagnostic criteria and outcome measures.

Main Results:

• Observational studies suggest some infants with mild HIE experience adverse neurodevelopmental outcomes.
• Evidence for TH efficacy and safety in mild HIE is inconclusive due to study limitations.
• Clinical practice for mild HIE management is inconsistent across regions.

Conclusions:

• Current evidence does not definitively prove neurodevelopmental benefit from TH in mild HIE.
• Concerns exist regarding potential overtreatment in some infants with mild HIE.
• Urgent need for large, prospective trials to establish risk-benefit profiles and standardize care.